1832 Asset Management L.P. Genmab A/S Transaction History

1832 Asset Management L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $79.1 Million - $94.8 Million	2,243,600 New	2,243,600 $79.1 Million
Q1 2023 May 12, 2023	SELL	$34.88 - $43.22 $1.53 Million - $1.9 Million	-44,000 Reduced 1.92%	2,243,600 $84.7 Million
Q4 2022 Feb 14, 2023	SELL	$33.8 - $47.06 $21,834 - $30,400	-646 Reduced 0.03%	2,287,600 $96.9 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $30 Million - $356 Million	952,346 Added 71.29%	2,288,246 $73.5 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $8.05 Million - $11.6 Million	-300,000 Reduced 18.34%	1,335,900 $43.4 Million
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $3.71 Million - $4.76 Million	-120,023 Reduced 6.84%	1,635,900 $58.4 Million
Q4 2021 Feb 15, 2022	BUY	$35.87 - $47.12 $825 - $1,083	23 Added 0.0%	1,755,923 $70.7 Million
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $4.14 Million - $5.61 Million	125,900 Added 7.72%	1,755,900 $72.7 Million
Q1 2021 May 17, 2021	SELL	$30.92 - $44.4 $1.55 Million - $2.22 Million	-50,000 Reduced 2.98%	1,630,000 $52 Million
Q4 2020 Feb 16, 2021	BUY	$33.66 - $40.76 $9.42 Million - $11.4 Million	280,000 Added 20.0%	1,680,000 $68.7 Million
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $30.8 Million - $36 Million	930,000 Added 197.87%	1,400,000 $52.6 Million
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $7.41 Million - $12.5 Million	369,600 Added 368.13%	470,000 $15.5 Million
Q1 2020 May 26, 2020	BUY	$17.15 - $25.22 $1.72 Million - $2.53 Million	100,400 New	100,400 $2.07 Million

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.